VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHOC 2022 | Recent advances in the treatment and management of ITP

Drew Provan, BSc, MBChB, MD, FRCP, FRCPath, Queen Mary University of London, London, UK, briefly discusses recent advances in the treatment and management of immune thrombocytopenia (ITP), commenting on changes being made in clinical practice and the importance of following more individualized treatment approaches. This interview took place at the XIII Eurasian Hematology-Oncology Congress (EHOC) held in Istanbul, Turkey.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research support: Amgen, Novartis
Honoraria: Amgen, Novartis, SOBI, UCB, argenx
Consultancies: UCB, MedImmune, Ono, SOBI, argenx

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter